Clinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroid cancer

Journal of Thyroid Research

Volumn 2011, Issue , 2011, Pages

  Cunha, L L ^a   Ferreira, R C ^a   Marcello, M A ^a   Vassallo, J ^a   Ward, L S ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CANCER VACCINE; CYTOKINE; PROTEIN RET; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROTROPIN; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; TOLL LIKE RECEPTOR 3;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CANCER GROWTH; CANCER IMMUNOTHERAPY; COMORBIDITY; DIFFERENTIATED THYROID CANCER; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA DAMAGE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HYPERTHYROIDISM; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; LYMPH NODE METASTASIS; LYMPHOCYTIC INFILTRATION; MOLECULAR BIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; THYROID CANCER; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA;

EID: 80052400954     PISSN: 20908067     EISSN: 20420072     Source Type: Journal    
DOI: 10.4061/2011/387062     Document Type: Review

References (161)

1. American Cancer Society, Cancer Facts & Figures, The Society, Atlanta, Ga, USA.
2. L. Davies and H. G. Welch, "Increasing incidence of thyroid cancer in the United States, 1973-2002, ", Journal of the American Medical Association, vol. 295, no. 18, pp. 2164-2167, 2006.
3. J. R. Burgess and P. Tucker, "Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine-needle aspirate cytology", Thyroid, vol. 16, no. 1, pp. 47-53, 2006. (Pubitemid 43346503)
4. B. A. Kilfoy, T. Zheng, T. R. Holford et al., "International patterns and trends in thyroid cancer incidence, 1973-2002", Cancer Causes and Control, vol. 20, no. 5, pp. 525-531, 2009.
5. Y. E. Nikiforov, "Is ionizing radiation responsible for the increasing incidence of thyroid cancer?" Cancer, vol. 116, no. 7, pp. 1626-1628, 2010.
6. L. Wartofsky, "Increasing world incidence of thyroid cancer: increased detection or higher radiation exposure?" Hormones, vol. 9, no. 2, pp. 103-108, 2010.
7. G. Pellegriti, F. De Vathaire, C. Scollo et al., "Papillary thyroid cancer incidence in the volcanic area of sicily", Journal of the National Cancer Institute, vol. 101, no. 22, pp. 1575-1583, 2009.
8. E. D. Williams, A. Abrosimov, T. Bogdanova et al., "Morphologic characteristics of Chernobyl-related childhood papillary thyroid carcinomas are independent of radiation exposure but vary with iodine intake", Thyroid, vol. 18, no. 8, pp. 847-852, 2008.
9. X. H. Liu, G. G. Chen, A. C. Vlantis, and C. A. Van Hasselt, "Iodine mediated mechanisms and thyroid carcinoma", Critical Reviews in Clinical Laboratory Sciences, vol. 46, no. 5-6, pp. 302-318, 2009.
10. A. Y. Chen, A. Jemal, and E. M. Ward, "Increasing incidence of differentiated thyroid cancer in the United States, 1988 2005", Cancer, vol. 115, no. 16, pp. 3801-3807, 2009.
11. A. G. Renehan, I. Soerjomataram, M. Tyson et al., "Incident cancer burden attributable to excess body mass index in 30 European countries", International Journal of Cancer, vol. 126, no. 3, pp. 692-702, 2010.
12. E. C. Morari, J. L. Pereira Leite, F. Granja, L. V. Montalli da Assumpcão, and L. S. Ward, "The null genotype of glutathione S-transferase M1 and T1 locus increases the risk for thyroid cancer", Cancer Epidemiology Biomarkers and Prevention, vol. 11, no. 11, pp. 1485-1488, 2002. (Pubitemid 35340389)
13. F. Granja, J. Morari, E. C. Morari, L. A. C. Correa, L. V. M. Assumpcao, and L. S. Ward, "GST profiling may be useful in the screening for thyroid nodule malignancy", Cancer Letters, vol. 209, no. 2, pp. 129-137, 2004. (Pubitemid 38670481)
14. 53 is a factor of susceptibility for thyroid cancer", Cancer Letters, vol. 210, no. 2, pp. 151-157, 2004. (Pubitemid 38748685)
15. F. Granja, E. C. Morari, L. V. M. Assumpcao, and L. S. Ward, "GSTO polymorphism analysis in thyroid nodules suggest that GSTO1 variants do not influence the risk for malignancy", European Journal of Cancer Prevention, vol. 14, no. 3, pp. 277-280, 2005. (Pubitemid 40780452)
16. N. E. Bufalo, J. L. Leite, A. C. T. Guilhen et al., "Smoking and susceptibility to thyroid cancer: an inverse association with CYP1A1 allelic variants", Endocrine-Related Cancer, vol. 13, no. 4, pp. 1185-1193, 2006. (Pubitemid 46212572)
17. A. C. T. Guilhen, N. E. Bufalo, E. C. Morari et al., "Role of the N-Acetyltransferase 2 Detoxification system in thyroid cancer susceptibility", Clinical Cancer Research, vol. 15, no. 1, pp. 406-412, 2009.
18. E. Ostroumova, A. Brenner, V. Oliynyk et al., "Subclinical hypothyroidism after radioiodine exposure: Ukrainian-American cohort study of thyroid cancer and other thyroid diseases after the chornobyl accident (1998&2000)", Environmental Health Perspectives, vol. 117, no. 5, pp. 745-750, 2009.
19. I. Gomez Segovia, H. J. Gallowitsch, E. Kresnik et al., "Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984-2001. Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: population-based agestratified analysis on thyroid carcinoma incidence", Thyroid, vol. 14, no. 4, pp. 277-286, 2004. (Pubitemid 38569277)
20. P. Laurberg, C. Cerqueira, L. Ovesen et al., "Iodine intake as a determinant of thyroid disorders in populations", Best Practice and Research, vol. 24, no. 1, pp. 13-27, 2010.
21. M. E. Dailey, S. Lindsay, and R. Skahen, "Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland", Archives of Surgery, vol. 70, no. 2, pp. 291-297, 1955.
22. G. Crile Jr. and E. R. Fisher, "Simultaneous occurrence of thyroiditis and papillary carcinoma; report of two cases", Cancer, vol. 6, no. 1, pp. 57-62, 1953.
23. R. N. Hirabayashi and S. Lindsay, "The relation of thyroid carcinoma and chronic thyroiditis", Surgery, Gynecology & Obstetrics, vol. 121, pp. 243-252, 1965.
24. C. P. Schlicke, J. E. Hill, and G. F. Schultz, "Carcinoma in chronic thyroiditis", Surgery, Gynecology & Obstetrics, vol. 111, pp. 552-556, 1960.
25. O. H. Clark, F. S. Greenspan, and J. E. Dunphy, "Hashimoto's thyroiditis and thyroid cancer: indications for operation", American Journal of Surgery, vol. 140, no. 1, pp. 65-71, 1980. (Pubitemid 10070055)
26. S. Lindsay, M. E. Dailey, J. Friedlander, G. Yee, and M. H. Soley, "Chronic thyroiditis: a clinical and pathologic study of 354 patients", The Journal of Clinical Endocrinology and Metabolism, vol. 12, no. 12, pp. 1578-1600, 1952.
27. D. W. Meier, O. H. Woolner, P. H. G. Beahrs, and C. W. Mc, "Parenchymal findings in thyroidal carcinoma: pathologic study of 256 cases", Journal of Clinical Endocrinology & Metabolism, vol. 19, no. 1, pp. 162-171, 1959.
28. E. Kebebew, P. A. Treseler, P. H. G. Ituarte, and O. H. Clark, "Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited", World Journal of Surgery, vol. 25, no. 5, pp. 632-637, 2001. (Pubitemid 32441438)
29. J. M. B. Bloodworth, J. Lechago, and V. E. Gould, Bloodworth's Endocrine Pathology, Williams & Wilkins, Baltimore, Md, USA, 3rd edition, 1996.
30. B. Singh, A. R. Shaha, H. Trivedi, J. F. Carew, A. Poluri, and J. P. Shah, "Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome", Surgery, vol. 126, no. 6, pp. 1070-1077, 1999.
31. L. S. Ward and L. V. M. Assumpcao, "The impact of gender in differentiated thyroid cancer", Clinical Endocrinology, vol. 66, no. 5, pp. 752-753, 2007.
32. P. S. De Matos, A. P. C. Ferreira, and L. S. Ward, "Prevalence of papillary microcarcinoma of the thyroid in Brazilian autopsy and surgical series", Endocrine Pathology, vol. 17, no. 2, pp. 165-173, 2006. (Pubitemid 44965905)
33. S. Matsubayashi, K. Kawai, Y. Matsumoto et al., "The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland", Journal of Clinical Endocrinology and Metabolism, vol. 80, no. 12, pp. 3419-3424, 1995.
34. K. Kashima, S. Yokoyama, S. Noguchi et al., "Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma", Thyroid, vol. 8, no. 3, pp. 197-202, 1998. (Pubitemid 28145182)
35. K. Asanuma, A. Sugenoya, Y. Kasuga, N. Itoh, S. Kobayashi, and J. Amano, "The relationship between multiple intrathyroidal involvement in papillary thyroid carcinoma and chronic non-specific thyroiditis", Cancer Letters, vol. 122, no. 1-2, pp. 177-180, 1998. (Pubitemid 28058633)
36. A. Schaffler, K. D. Palitzsch, C. Seiffarth et al., "Coexistent thyroiditis is associated with lower tumour stage in thyroid carcinoma", European Journal of Clinical Investigation, vol. 28, no. 10, pp. 838-844, 1998. (Pubitemid 28488118)
37. K. C. Loh, F. S. Greenspan, F. Dong, T. R. Miller, and P. P. B. Yeo, "Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma", Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 2, pp. 458-463, 1999. (Pubitemid 29075669)
38. S. Lisboa Souza, L. Vera Montalli da Assumpcao, and L. Sterian Ward, "Impact of previous thyroid autoimmune diseases on prognosis of patients with well-differentiated thyroid cancer", Thyroid, vol. 13, no. 5, pp. 491-495, 2003. (Pubitemid 36750560)
39. S. K. Kim, K. H. Song, SO. D. Lim et al., "Clinical and pathological features and the BRAF mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis", Thyroid, vol. 19, no. 2, pp. 137-141, 2009.
40. E. Y. Kim, W. G. Kim, W. B. Kim et al., "Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma", Clinical Endocrinology, vol. 71, no. 4, pp. 581-586, 2009.
41. M. Muzza, D. Degl'Innocenti, C. Colombo et al., "The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies", Clinical Endocrinology, vol. 72, no. 5, pp. 702-708, 2010.
42. H. S. Kim, Y. J. Choi, and JI. S. Yun, "Features of papillary thyroid microcarcinoma in the presence and absence of lymphocytic thyroiditis", Endocrine Pathology, pp. 1-5, 2010.
43. B. Rapoport and S. M. McLachlan, "Thyroid autoimmunity", Journal of Clinical Investigation, vol. 108, no. 9, pp. 1253-1259, 2001. (Pubitemid 33107748)
44. L. A. Zenewicz, C. Abraham, R. A. Flavell, and J. H. Cho, "Unraveling the genetics of autoimmunity", Cell, vol. 140, no. 6, pp. 791-797, 2010.
45. A. W. Michels and G. S. Eisenbarth, "Immunologic endocrine disorders", Journal of Allergy and Clinical Immunology, vol. 125, no. 2, pp. S226-S237, 2010.
46. C. L. Burek and N. R. Rose, "Autoimmune thyroiditis and ROS", Autoimmunity Reviews, vol. 7, no. 7, pp. 530-537, 2008.
47. Y. Tomer and F. Menconi, "Interferon induced thyroiditis", Best Practice and Research, vol. 23, no. 6, pp. 703-712, 2009.
48. J. C. Flynn, D. J. McCormick, V. Brusic et al., "Pathogenic human thyroglobulin peptides in HLA-DR3 transgenic mouse model of autoimmune thyroiditis", Cellular Immunology, vol. 229, no. 2, pp. 79-85, 2004. (Pubitemid 39330215)
49. F. Pacifico and A. Leonardi, "Role of NF-kB in thyroid cancer", Molecular and Cellular Endocrinology, vol. 321, no. 1, pp. 29-35, 2010.
50. C. Anil, S. Goksel, and A. Gursoy, "Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules", Thyroid, vol. 20, no. 8, pp. 885-891, 2010.
51. Drug Discovery Today, Elsevier Science, Oxford, UK, 10th edition, 2004.
52. S. Shu, G. E. Plautz, J. C. Krauss, and A. E. Chang, "Tumor immunology", Journal of the American Medical Association, vol. 278, no. 22, pp. 1972-1981, 1997. (Pubitemid 28007272)
53. E. H. Lipford III, J. C. Eggleston, and K. D. Lillemoe, "Prognostic factors in surgically resected limited-stage, nonsmall cell carcinoma of the lung", American Journal of Surgical Pathology, vol. 8, no. 5, pp. 357-365, 1984. (Pubitemid 14148460)
54. A. Kawata, Y. Une, M. Hosokawa, J. Uchino, and H. Kobayashi, "Tumor-infiltrating lymphocytes and prognosis of hepatocellular carcinoma", Japanese Journal of Clinical Oncology, vol. 22, no. 4, pp. 256-263, 1992.
55. P. C. Kolbeck, F. F. Kaveggia, S. L. Johansson, M. T. Grune, and R. J. Taylor, "The relationships among tumorinfiltrating lymphocytes, histopathologic findings, and longterm clinical follow-up in renal cell carcinoma", Modern Pathology, vol. 5, no. 4, pp. 420-425, 1992.
56. C. M. Boyd and J. R. Baker, "The immunology of thyroid cancer", Endocrinology and Metabolism Clinics of North America, vol. 25, no. 1, pp. 159-179, 1996. (Pubitemid 26082767)
57. D. M. Tamimi, "The association between chronic lymphocytic thyroiditis and thyroid tumors", International Journal of Surgical Pathology, vol. 10, no. 2, pp. 141-146, 2002. (Pubitemid 34655100)
58. K. Gul, A. Dirikoc, G. Kiyak et al., "The association between thyroid carcinoma and Hashimoto's thyroiditis: the ultrasonographic and histopathologic characteristics of malignant nodules", Thyroid, vol. 20, no. 8, pp. 873-878, 2010.
59. J. H. Shull, N. Sharon, T. A. Victor, and E. F. Scanlon, "Thyroid carcinoma. Immunology, irradiation, and lymphocytic infiltration", Archives of Surgery, vol. 114, no. 6, pp. 729-731, 1979. (Pubitemid 9228863)
60. H. Kamma, K. Fujii, and T. Ogata, "Lymphocytic infiltration in juvenile thyroid carcinoma", Cancer, vol. 62, no. 9, pp. 1988-1993, 1988. (Pubitemid 18261825)
61. R. S. Sundick, "Iodine in autoimmune thyroiditis", Immunology series, vol. 52, pp. 213-228, 1990.
62. F. Boi, M. L. Lai, B. Marziani, L. Minerba, G. Faa, and S. Mariotti, "High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies", European Journal of Endocrinology, vol. 153, no. 5, pp. 637-642, 2005. (Pubitemid 41672409)
63. E. Fiore, T. Rago, M. Scutari et al., "Papillary thyroid cancer, although strongly associated with lymphocitic infiltration on histology, is only weakly predicted by serum thyroid autoantibodies in patients with nodular thyroid diseases", Journal of Endocrinological Investigation, vol. 32, no. 4, pp. 344-351, 2009.
64. K. Boelaert, J. Horacek, R. L. Holder, J. C. Watkinson, M. C. Sheppard, and J. A. Franklyn, "Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration", Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 11, pp. 4295-4301, 2006. (Pubitemid 44833401)
65. T. Rago, G. Di Coscio, C. Ugolini et al., "Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy", Clinical Endocrinology, vol. 67, no. 3, pp. 363-369, 2007. (Pubitemid 47283831)
66. E. Fiore, T. Rago, M. A. Provenzale et al., "Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role", Endocrine-Related Cancer, vol. 16, no. 4, pp. 1251-1260, 2009.
67. M. Erdogan, N. Erdem, S. Cetinkalp et al., "Demographic, clinical, laboratory, ultrasonographic, and cytological features of patients with Hashimoto's thyroiditis: results of a university hospital of 769 patients in Turkey", Endocrine, vol. 36, no. 3, pp. 486-490, 2009.
68. H. J. Carson, M. J. Castelli, and P. Gattuso, "Incidence of neoplasia in Hashimoto's thyroiditis: a fine-needle aspiration study", Diagnostic Cytopathology, vol. 14, no. 1, pp. 38-42, 1996. (Pubitemid 26044639)
69. E. L. Mazzaferri, "Thyroid cancer and Graves' disease", Journal of Clinical Endocrinology and Metabolism, vol. 70, no. 4, pp. 826-829, 1990. (Pubitemid 20138591)
70. E. L. Mazzaferri, "Thyroid cancer and Graves' disease: the controversy ten years later", Endocrine Practice, vol. 6, no. 2, pp. 221-225, 2000.
71. A. Belfiore, M. R. Garofalo, D. Giuffrida et al., "Increased aggressiveness of thyroid cancer in patients with Graves' disease", Journal of Clinical Endocrinology and Metabolism, vol. 70, no. 4, pp. 830-835, 1990.
72. G. Pellegriti, A. Belfiore, D. Giuffrida, L. Lupo, and R. Vigneri, "Outcome of differentiated thyroid cancer in Graves' patients", Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 8, pp. 2805-2809, 1998. (Pubitemid 28493780)
73. A. Belfiore, D. Russo, R. Vigneri, and S. Filetti, "Graves' disease, thyroid nodules and thyroid cancer", Clinical Endocrinology, vol. 55, no. 6, pp. 711-718, 2001. (Pubitemid 34008739)
74. Y. Yano, H. Shibuya, W. Kitagawa et al., "Recent outcome of grave's disease patients with papillary thyroid cancer", European Journal of Endocrinology, vol. 157, no. 3, pp. 325-329, 2007. (Pubitemid 47603537)
75. I. B. Hales, A. McElduff, P. Crummer et al., "Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer", Journal of Clinical Endocrinology and Metabolism, vol. 75, no. 3, pp. 886-889, 1992.
76. L. J. DeGroot, E. L. Kaplan, M. McCormick, and F. H. Straus, "Natural history, treatment, and course of papillary thyroid carcinoma", Journal of Clinical Endocrinology and Metabolism, vol. 71, no. 2, pp. 414-424, 1990.
77. O. H. Clark, "Predictors of thyroid tumor aggressiveness", Western Journal of Medicine, vol. 165, no. 3, pp. 131-138, 1996. (Pubitemid 126446762)
78. F. Balkwill and A. Mantovani, "Inflammation and cancer: back to virchow?" Lancet, vol. 357, no. 9255, pp. 539-545, 2001. (Pubitemid 32173595)
79. P. Correa, "Human gastric carcinogenesis: a multistep and multifactorial process-first American Cancer Society Award lecture on cancer epidemiology and prevention", Cancer Research, vol. 52, no. 24, pp. 6735-6740, 1992. (Pubitemid 23006271)
80. A. Ekbom, C. Helmick, M. Zack, and H. O. Adami, "Ulcerative colitis and colorectal cancer: a population-based study", New England Journal of Medicine, vol. 323, no. 18, pp. 1228-1233, 1990. (Pubitemid 20366527)
81. A. C. De Vries, J. Haringsma, and E. J. Kuipers, "The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection", Helicobacter, vol. 12, no. 1, pp. 1-15, 2007. (Pubitemid 46105914)
82. A. C. de Vries, N. C. T. van Grieken, C. W. N. Looman et al., "Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands", Gastroenterology, vol. 134, no. 4, pp. 945-952, 2008. (Pubitemid 351451990)
83. A. P. Weetman, "Cellular immune responses in autoimmune thyroid disease", Clinical Endocrinology, vol. 61, no. 4, pp. 405-413, 2004. (Pubitemid 39388475)
84. R. Ciampi and Y. E. Nikiforov, "Minireview: RET/PTC rearrangements and braf mutations in thyroid tumorigenesis", Endocrinology, vol. 148, no. 3, pp. 936-941, 2007.
85. C. Zafon and G. Obiols, "The mitogen-activated protein kinase (MAPK) signaling pathway in papillary thyroid cancer. From the molecular bases to clinical practiceVIa de senalizacion dependiente de la proteincinasa de activacion mitogenica en el carcinoma papilar de tiroides. De las bases moleculares a la practica clinica", Endocrinologia y Nutricion, vol. 56, no. 4, pp. 176-186, 2009.
86. M. Xing, "BRAF mutation in thyroid cancer", Endocrine-Related Cancer, vol. 12, no. 2, pp. 245-262, 2005. (Pubitemid 40896444)
87. R. H. Williams and P. R. Larsen, Williams Textbook of Endocrinology, Saunders, Philadelphia, Pa, USA, 10th edition, 2003.
88. A. Wirtschafter, R. Schmidt, D. Rosen et al., "Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis", Laryngoscope, vol. 107, no. 1, pp. 95-100, 1997. (Pubitemid 27045201)
89. O. M. Sheils, J. J. O'Leary, V. Uhlmann, K. Luttich, and E. C. Sweeney, "ret/PTC-1 activation in Hashimoto thyroiditis", International Journal of Surgical Pathology, vol. 8, no. 3, pp. 185-189, 2000.
90. R. Elisei, C. Romei, T. Vorontsova et al., "RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults", Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 7, pp. 3211-3216, 2001. (Pubitemid 32673490)
91. K. J. Rhoden, K. Unger, G. Salvatore et al., "RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma", Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 6, pp. 2414-2423, 2006. (Pubitemid 43855035)
92. D. Y. Kang, K. H. Kim, J. M. Kim et al., "High prevalence of RET, RAS, and ERK expression in Hashimoto's thyroiditis and in papillary thyroid carcinoma in the Korean population", Thyroid, vol. 17, no. 11, pp. 1031-1038, 2007.
93. V. Guarino, M. D. Castellone, E. Avilla, and R. M. Melillo, "Thyroid cancer and inflammation", Molecular and Cellular Endocrinology, vol. 321, no. 1, pp. 94-102, 2010.
94. L. M. Coussens and Z. Werb, "Inflammation and cancer", Nature, vol. 420, no. 6917, pp. 860-867, 2002. (Pubitemid 36019639)
95. F. Colotta, P. Allavena, A. Sica, C. Garl and A. Mantovani, "Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability", Carcinogenesis, vol. 30, no. 7, pp. 1073-1081, 2009.
96. M. D. Castellone, A. M. Cirafici, G. De Vita et al., "Rasmediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes", Oncogene, vol. 22, no. 2, pp. 246-255, 2003. (Pubitemid 36174181)
97. J. Wang, J. A. Knauf, S. Basu et al., "Conditional expression of RET/PTC induces a weak oncogenic drive in thyroid PCCL3 cells and inhibits thyrotropin action at multiple levels", Molecular Endocrinology, vol. 17, no. 7, pp. 1425-1436, 2003. (Pubitemid 36819961)
98. G. Stassi, M. Todaro, M. Zerilli et al., "Thyroid cancer resistance to chemotherapeutic drugs via autocrine production of interleukin-4 and interleukin-10", Cancer Research, vol. 63, no. 20, pp. 6784-6790, 2003. (Pubitemid 37322959)
99. C. Conticello, F. Pedini, A. Zeuner et al., "IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via upregulation of antiapoptotic proteins", Journal of Immunology, vol. 172, no. 9, pp. 5467-5477, 2004. (Pubitemid 38542047)
100. M. Todaro, Y. Lombardo, M. G. Francipane et al., "Apoptosis resistance in epithelial tumors is mediated by tumor-cellderived interleukin-4", Cell Death and Differentiation, vol. 15, no. 4, pp. 762-772, 2008. (Pubitemid 351405081)
101. J. P. Russell, S. Shinohara, R. M. Melillo, M. D. Castellone, M. Santoro, and J. L. Rothstein, "Tyrosine kinase oncoprotein, RET/PTC3, induces the secretion of myeloid growth and chemotactic factors", Oncogene, vol. 22, no. 29, pp. 4569-4577, 2003. (Pubitemid 36920700)
102. J. P. Russell, J. B. Engiles, and J. L. Rothstein, "Proinflammatory mediators and genetic background in oncogene mediated tumor progression", Journal of Immunology, vol. 172, no. 7, pp. 4059-4067, 2004. (Pubitemid 38375217)
103. E. Puxeddu, N. Mitsutake, J. A. Knauf et al., "Microsomal prostaglandin E2 synthase-1 is induced by conditional expression of RET/PTC in thyroid PCCL3 cells through the activation of the MEK-ERK pathway", Journal of Biological Chemistry, vol. 278, no. 52, pp. 52131-52138, 2003. (Pubitemid 38035799)
104. S. Shinohara and J. L. Rothstein, "Interleukin 24 is induced by the RET/PTC3 oncoprotein and is an autocrine growth factor for epithelial cells", Oncogene, vol. 23, no. 45, pp. 7571-7579, 2004. (Pubitemid 39389698)
105. E. Puxeddu, J. A. Knauf, M. A. Sartor et al., "RET/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response", Endocrine-Related Cancer, vol. 12, no. 2, pp. 319-334, 2005. (Pubitemid 40896450)
106. H. Sumimoto, F. Imabayashi, T. Iwata, and Y. Kawakami, "The BRAF-MAPK signaling pathway is essential for cancerimmune evasion in human melanoma cells", Journal of Experimental Medicine, vol. 203, no. 7, pp. 1651-1656, 2006. (Pubitemid 44036269)
107. S. Crawford, D. Belajic, J. Wei et al., "A novel B-RAF inhibitor blocks interleukin-8 (IL-8) synthesis in human melanoma xenografts, revealing IL-8 as a potential pharmacodynamic biomarker", Molecular Cancer Therapeutics, vol. 7, no. 3, pp. 492-499, 2008. (Pubitemid 351482132)
108. H. R. Harach, "Solid cell nests of the thyroid", Journal of Pathology, vol. 155, no. 3, pp. 191-200, 1988.
109. J. Cameselle-Teijeiro, J. Varela-Duran, C. Sambade, J. P. Villanueva, R. Varela-Nunez, and M. Sobrinho-Simoes, "Solid cell nests of the thyroid: light microscopy and immunohistochemical profile", Human Pathology, vol. 25, no. 7, pp. 684-693, 1994. (Pubitemid 24230747)
110. V. Martin, L. Martin, G. Viennet, M. Hergel, J. P. Carbillet, and D. Fellmann, "Ultrastructural features of 'solid cell nest' of the human thyroid gland: a study of 8 cases", Ultrastructural Pathology, vol. 24, no. 1, pp. 1-8, 2000. (Pubitemid 30129773)
111. H. Ruben Harach, "Mixed follicles of the human thyroid gland", Acta Anatomica, vol. 129, no. 1, pp. 27-30, 1987.
112. V. L. Bykov, "Tissue of ultimobranchial origin in normal and pathologically altered thyroid gland", Arkhiv Patologii, vol. 55, no. 5, pp. 81-84, 1993.
113. B. A. Fraser and J. W. A. Duckworth, "Ultimobranchial body cysts in the human foetal thyroid: pathological implications", Journal of Pathology, vol. 127, no. 2, pp. 89-92, 1979. (Pubitemid 9153391)
114. Y. Mizukami, A. Nonomura, T. Michigishi et al., "Solid cell nests of the thyroid: a histologic and immunohistochemical study", American Journal of Clinical Pathology, vol. 101, no. 2, pp. 186-191, 1994. (Pubitemid 24061446)
115. O. Ozaki, K. Ito, K. Sugino et al., "Solid cell nests of the thyroid gland", Virchows Archiv-A Pathological Anatomy and Histopathology, vol. 418, no. 3, pp. 201-205, 1991.
116. M. E. Beckner, J. J. Shultz, and T. Richardson, "Solid and cystic ultimobranchial body remnants in the thyroid", Archives of Pathology and Laboratory Medicine, vol. 114, no. 10, pp. 1049-1052, 1990. (Pubitemid 20326692)
117. V. Martin, L. Martin, G. Viennet, B. Challier, J. P. Carbillet, and D. Fellmann, "Solid cell nests and thyroid pathologies. Retrospective study of 1, 390 thyroids", Annales de Pathologie, vol. 20, no. 3, pp. 196-201, 2000. (Pubitemid 30484154)
118. J. K. C. Chan and C. C. H. Tse, "Solid cell nest-associated C-cells: another possible explanation for "C-cell hyperplasia" adjacent to follicular cell tumors", Human Pathology, vol. 20, no. 5, pp. 498-499, 1989.
119. J. Cameselle-Teijeiro, C. Febles-Perez, and M. Sobrinho-Simoes, "Papillary and mucoepidermoid carcinoma of the thyroid with anaplastic transformation. A case report with histologic and immunohistochemical findings that support a provocative histogenetic hypothesis", Pathology Research and Practice, vol. 191, no. 12, pp. 1214-1221, 1995. (Pubitemid 26060404)
120. E. D. Williams, C. E. Toyn, and H. R. Harach, "The ultimobranchial gland and congenital thyroid abnormalities in man", Journal of Pathology, vol. 159, no. 2, pp. 135-141, 1989. (Pubitemid 19257231)
121. 63 in papillary thyroid carcinoma and in Hashimoto's thyroiditis: a pathobiologic link?" Human Pathology, vol. 34, no. 8, pp. 764-769, 2003. (Pubitemid 37040611)
122. 63 in solid cell nests, papillary thyroid carcinoma, and Hashimoto's thyroiditis: a stem cell Hypothesis of papillary carcinoma oncogenesis", Human Pathology, vol. 35, no. 4, pp. 465-473, 2004. (Pubitemid 38507084)
123. A. Preto, J. Cameselle-Teijeiro, J. Moldes-Boullosa et al., "Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests", Modern Pathology, vol. 17, no. 7, pp. 819-826, 2004. (Pubitemid 38849387)
124. S. Asioli, L. A. Erickson, and R. V. Lloyd, "Solid cell nests in hashimoto's thyroiditis sharing features with papillary thyroid microcarcinoma", Endocrine Pathology, vol. 20, no. 4, pp. 197-203, 2009.
125. 63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin", Modern Pathology, vol. 16, no. 1, pp. 43-48, 2003. (Pubitemid 36152685)
126. I. Vollenweider and C. Hedinger, "Solid cell nests (SCN) in Hashimoto's thyroiditis", Virchows Archiv-A Pathological Anatomy and Histopathology, vol. 412, no. 4, pp. 357-363, 1988. (Pubitemid 18064573)
127. G. Prod'hom and C. Hedinger, "Relationship between solid cell nests and focal lymphocytic thyroiditis", Annales de Pathologie, vol. 5, no. 4-5, pp. 265-270, 1985. (Pubitemid 16140026)
128. J. Cameselle-Teijeiro, I. Abdulkader, R. Perez-Becerra et al., "BRAF mutation in solid cell nest hyperplasia associated with papillary thyroid carcinoma. A precursor lesion?" Human Pathology, vol. 40, no. 7, pp. 1029-1035, 2009.
129. N. Harii, C. J. Lewis, V. Vasko et al., "Thyrocytes express a functional Toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto's autoimmune thyroiditis", Molecular Endocrinology, vol. 19, no. 5, pp. 1231-1250, 2005. (Pubitemid 40594121)
130. K. Takeda and S. Akira, "Microbial recognition by Toll-like receptors", Journal of Dermatological Science, vol. 34, no. 2, pp. 73-82, 2004. (Pubitemid 38368945)
131. D. M. Underhill, "Toll-like receptors: networking for success", European Journal of Immunology, vol. 33, no. 7, pp. 1767-1775, 2003. (Pubitemid 37120847)
132. G. M. Barton and R. Medzhitov, "Toll-like receptor signaling pathways", Science, vol. 300, no. 5625, pp. 1524-1525, 2003. (Pubitemid 36682871)
133. K. Takeda, T. Kaisho, and S. Akira, "Toll-like receptors", Annual Review of Immunology, vol. 21, pp. 335-376, 2003. (Pubitemid 37174535)
134. M. Muzio, D. Bosisio, N. Polentarutti et al., "Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells", Journal of Immunology, vol. 164, no. 11, pp. 5998-6004, 2000. (Pubitemid 30389848)
135. K. D. McCall, N. Harii, C. J. Lewis et al., "High basal levels of functional Toll-Like Receptor 3 (TLR3) and noncanonical Wnt5a are expressed in papillary thyroid cancer and are coordinately decreased by phenylmethimazole together with cell proliferation and migration", Endocrinology, vol. 148, no. 9, pp. 4226-4237, 2007. (Pubitemid 47295676)
136. A. Sancar, L. A. Lindsey-Boltz, K. Unsal-Kacmaz, and S. Linn, "Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints", Annual Review of Biochemistry, vol. 73, pp. 39-85, 2004. (Pubitemid 39050363)
137. S. Gasser and D. Raulet, "The DNA damage response, immunity and cancer", Seminars in Cancer Biology, vol. 16, no. 5, pp. 344-347, 2006. (Pubitemid 44311502)
138. G. G. Gomez, M. J. Hickey, R. Tritz, and C. A. Kruse, "Immunoresistant human glioma cell clones selected with alloreactive cytotoxic T lymphocytes: downregulation of multiple proapoptotic factors", Gene Therapy and Molecular Biology, vol. 12, no. 1, pp. 101-110, 2008.
139. S. Gasser, S. Orsulic, E. J. Brown, and D. H. Raulet, "The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor", Nature, vol. 436, no. 7054, pp. 1186-1190, 2005. (Pubitemid 41232299)
140. N. M. Akulevich, V. A. Saenko, T. I. Rogounovitch et al., "Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma", Endocrine-Related Cancer, vol. 16, no. 2, pp. 491-503, 2009.
141. S. L. Dombernowsky, M. Weischer, K. H. Allin, S. E. Bojesen, A. Tybjærg-Hansen, and B. G. Nordestgaard, "Risk of cancer by ATM missense mutations in the general population", Journal of Clinical Oncology, vol. 26, no. 18, pp. 3057-3062, 2008.
142. M. C. Royer, H. Zhang, C. Y. Fan, and M. S. Kokoska, "Genetic alterations in papillary thyroid carcinoma and hashimoto thyroiditis: an analysis of hOGG1 loss of heterozygosity", Archives of Otolaryngology, vol. 136, no. 3, pp. 240-242, 2010.
143. O. Ozaki, K. Ito, K. Kobayashi, K. Toshima, H. Iwasaki, and T. Yashiro, "Thyroid carcinoma in Graves' disease", World Journal of Surgery, vol. 14, no. 3, pp. 437-440, 1990.
144. S. Gupta, A. Patel, A. Folstad et al., "Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults", Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 3, pp. 1346-1354, 2001. (Pubitemid 32323027)
145. D. R. Maceri, M. J. Sullivan, and K. D. McClatchney, "Autoimmune thyroiditis: pathophysiology and relationship to thyroid cancer", Laryngoscope, vol. 96, no. 1, pp. 83-86, 1986. (Pubitemid 16183419)
146. G. Crile, "Struma lymphomatosa and carcinoma of the thyroid", Surgery Gynecology and Obstetrics, vol. 147, no. 3, pp. 350-352, 1978.
147. L. E. Holm, H. Blomgren, and T. Lowhagen, "Cancer risks in patients with chronic lymphocytic thyroiditis", New England Journal of Medicine,
148. A. M. D. O. Ramos, A. D. O. Sales, L. E. Barbalho De Mello et al., "Absence of peritumoral fibrosis or inflammatory infiltrate may be related to clinical progression of papillary thyroid microcarcinoma", International Journal of Surgical Pathology, vol. 17, no. 6, pp. 432-437, 2009.
149. S. D. Lucas, A. Karlsson-Parra, BO. Nilsson et al., "Tumorspecific deposition of immunoglobulin g and complement in papillary thyroid carcinoma", Human Pathology, vol. 27, no. 12, pp. 1329-1335, 1996. (Pubitemid 26415328)
150. G. H. Sakorafas, J. Giotakis, and V. Stafyla, "Papillary thyroid microcarcinoma: a surgical perspective", Cancer Treatment Reviews, vol. 31, no. 6, pp. 423-438, 2005. (Pubitemid 41536166)
151. L. Falvo, C. D'Ercole, S. Sorrenti et al., "Papillary microcarcinoma of the thyroid gland: analysis of prognostic factors including histological subtype", European Journal of Surgery, Supplement, vol. 168, no. 588, pp. 28-32, 2003. (Pubitemid 36918754)
152. O. Ozaki, K. Ito, T. Mimura, K. Sugino, and Y. Hosoda, "Papillary carcinoma of the thyroid: tall-cell variant with extensive lymphocyte infiltration", American Journal of Surgical Pathology, vol. 20, no. 6, pp. 695-698, 1996. (Pubitemid 26147466)
153. K. Segal, M. Ben-Bassat, and A. Avraham, "Hashimoto's thyroiditis and carcinoma of the thyroid gland", International Surgery, vol. 70, no. 3, pp. 205-209, 1985. (Pubitemid 16131950)
154. C. Papewalis, M. Ehlers, and M. Schott, "Advances in cellular therapy for the treatment of thyroid cancer", Journal of Oncology, p. 179491, 2010.
155. Z. Wang, G. Chakravarty, S. Kim et al., "Growth-inhibitory effects of human anti-insulin-like growth factor-1 receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma", Clinical Cancer Research, vol. 12, no. 15, pp. 4755-4765, 2006. (Pubitemid 44297830)
156. S. Kim, C. N. Prichard, M. N. Younes et al., "Cetuximab and irinotecan interact synergistically to inhibit the growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice", Clinical Cancer Research, vol. 12, no. 2, pp. 600-607, 2006. (Pubitemid 43166155)
157. C. S. Mitsiades, N. S. Mitsiades, C. J. McMullan et al., "Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors", Cancer Cell, vol. 5, no. 3, pp. 221-230, 2004. (Pubitemid 38402114)
158. M. Schott, J. Feldkamp, M. Klucken, G. Kobbe, W. A. Scherbaum, and J. Seissler, "Calcitonin-specific antitumor immunity in medullary thyroid carcinoma following dendritic cell vaccination", Cancer Immunology, Immunotherapy, vol. 51, no. 11-12, pp. 663-668, 2002. (Pubitemid 35440520)
159. M. Schott, J. Seissler, M. Lettmann, V. Fouxon, W. A. Scherbaum, and J. Feldkamp, "Immunotherapy for medullary thyroid carcinoma by dendritic cell vaccination", Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 10, pp. 4965-4969, 2001. (Pubitemid 33020550)
160. C. Papewalis, B. Jacobs, M. Wuttke et al., "IFN-a skews monocytes into CD56-expressing dendritic cells with potent functional activities in vitro and in vivo", Journal of Immunology, vol. 180, no. 3, pp. 1462-1470, 2008.
161. C. Papewalis, M. Wuttke, B. Jacobs et al., "Dendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma", Hormone and Metabolic Research, vol. 40, no. 2, pp. 108-116, 2008. (Pubitemid 351363421)